• Return to Headlines

Amedisys Looks to Continue to Trade Above its Annual-High Share Price Today

By James Quinn

Shares of Amedisys (NASDAQ:AMED) traded at a new 52-week high today of $63.45. So far today approximately 59,000 shares have been exchanged, as compared to an average 30-day volume of 324,000 shares.

Based on a current price of $63.45, Amedisys is currently 22.9% above its average consensus analyst price target of $48.89. The stock should discover initial support at its 50-day moving average (MA) of $45.63 and subsequent support at its 200-day MA of $41.34.

Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States.

In the past 52 weeks, shares of Amedisys have traded between a low of $26.05 and a high of $63.45 and are now at $63.45, which is 144% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 2.6%.

SmarTrend recommended that subscribers consider buying shares of Amedisys on December 16th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $42.61. Since that recommendation, shares of Amedisys have risen 47.1%. We continue to monitor AMED for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows Amedisys

Ticker(s): AMED